Impact of Gestational Weight Gain on Pregnancy-Related Breast Cancer and Validation of a Nomogram - Top-Institutions - MDSpire

Impact of Gestational Weight Gain on Pregnancy-Related Breast Cancer and Validation of a Nomogram

  • By

  • Chenguang Liu

  • Ruifeng Wang

  • Shoujun Wang

  • Shiyang Liu

  • Xinhong Wu

  • Weihong Zheng

  • Shuyu Li

  • Tianyao Yu

  • Jie Hao

  • Lin Zhang

  • November 29, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Oncology
    • Cancer Epidemiology
    • Maternal-Fetal Medicine

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Surgical Oncology
    • Cancer Epidemiology
    • Maternal-Fetal Medicine

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Oncology
    • Cancer Epidemiology
    • Obstetrics and Gynecology

  • #4

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Breast Oncology
    • Maternal-Fetal Medicine
    • Epidemiology

  • #5

    National Cancer Center Hospital
    National Cancer Center Hospital

    Tokyo, Tokyo Prefecture

    Key Differentiators

    • Breast Oncology
    • Cancer Epidemiology
    • Obstetrics and Gynecology

Original Source(s)

Impact of Gestational Weight Gain on Pregnancy-Related Breast Cancer and Validation of a Nomogram

  • by Chenguang Liu, Ruifeng Wang, Shoujun Wang, Shiyang Liu, Xinhong Wu, Weihong Zheng, Shuyu Li, Tianyao Yu, Jie Hao, Lin Zhang

  • November 29, 2025

Related Content

Potential targets for boron transport in boron neutron capture therapy

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report

Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer